Literature DB >> 2045139

Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats.

B Escalante1, D Sacerdoti, M M Davidian, M Laniado-Schwartzman, J C McGiff.   

Abstract

We have reported that short-term treatment of spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats with stannous chloride (SnCl2), which selectively depletes renal cytochrome P450, restores blood pressure to normal in young but not in adult SHR, and is without effect on blood pressure of either young or adult WKY rats. We report in the present study that chronic treatment with SnCl2, begun at age 5 weeks, prevented the development of hypertension in SHR over a period of 15 weeks at which time they were killed. Suspension of SnCl2 treatment after 8 weeks (i.e., at age 13 weeks) did not result in return of blood pressure to hypertensive levels in SHR. Age-matched WKY rats were not affected by tin treatment. These findings provide additional evidence that administration of tin, which stimulates heme oxygenase, thereby producing depletion of cytochrome P450, restores blood pressure to normal levels in SHR.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045139     DOI: 10.1161/01.hyp.17.6.776

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension.

Authors:  David Sacerdoti; Houli Jiang; Silvia Gaiani; John C McGiff; Angelo Gatta; Massimo Bolognesi
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-08-11       Impact factor: 3.072

Review 2.  20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension.

Authors:  Jan M Williams; Sydney Murphy; Marilyn Burke; Richard J Roman
Journal:  J Cardiovasc Pharmacol       Date:  2010-10       Impact factor: 3.105

3.  Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.

Authors:  Kathryn M Dunn; Marija Renic; Averia K Flasch; David R Harder; John Falck; Richard J Roman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-24       Impact factor: 4.733

4.  Activation of vascular endothelial nitric oxide synthase and heme oxygenase-1 expression by electrophilic nitro-fatty acids.

Authors:  Nicholas K H Khoo; Volker Rudolph; Marsha P Cole; Franca Golin-Bisello; Francisco J Schopfer; Steven R Woodcock; Carlos Batthyany; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2009-10-24       Impact factor: 7.376

Review 5.  20-HETE in the regulation of vascular and cardiac function.

Authors:  Petra Rocic; Michal Laniado Schwartzman
Journal:  Pharmacol Ther       Date:  2018-07-23       Impact factor: 12.310

6.  Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.

Authors:  Cheng-Chia Wu; Shaojun Mei; Jennifer Cheng; Yan Ding; Adam Weidenhammer; Victor Garcia; Fan Zhang; Katherine Gotlinger; Vijaya L Manthati; John R Falck; Jorge H Capdevila; Michal L Schwartzman
Journal:  J Am Soc Nephrol       Date:  2013-05-02       Impact factor: 10.121

7.  Bisphenol F Exposure in Adolescent Heterogeneous Stock Rats Affects Growth and Adiposity.

Authors:  Valerie A Wagner; Karen C Clark; Leslie Carrillo-Sáenz; Katie A Holl; Miriam Velez-Bermudez; Derek Simonsen; Justin L Grobe; Kai Wang; Andrew Thurman; Leah C Solberg Woods; Hans-Joachim Lehmler; Anne E Kwitek
Journal:  Toxicol Sci       Date:  2021-05-27       Impact factor: 4.849

8.  Role of HO/CO in the Control of Peripheral Circulation in Humans.

Authors:  David Sacerdoti; Despina Mania; Paola Pesce; Silvia Gaiani; Angelo Gatta; Massimo Bolognesi
Journal:  Int J Hypertens       Date:  2012-03-04       Impact factor: 2.420

Review 9.  Harnessing the cardiovascular benefits of exercise: Are Nrf2 activators useful?

Authors:  Babatunde Fasipe; Shunchang Li; Ismail Laher
Journal:  Sports Med Health Sci       Date:  2021-05-04

Review 10.  Nrf2 and cardiovascular defense.

Authors:  Reuben Howden
Journal:  Oxid Med Cell Longev       Date:  2013-04-04       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.